Dog Skin Biopsy: When It's Needed, What to Expect & Results

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated March 2026  ·  9 min read

Photo by Tima Miroshnichenko on Pexels

Chronic skin disease in dogs presents one of the most common diagnostic challenges in veterinary dermatology. Many canine skin conditions produce remarkably similar clinical appearances, scaling, alopecia, erythema, and secondary bacterial or yeast colonization, yet have fundamentally different underlying etiologies requiring vastly different therapeutic approaches. When topical and systemic treatments fail to resolve skin disease, when clinical presentation is ambiguous, or when multiple diagnoses seem possible, a skin biopsy provides the definitive diagnostic information necessary to establish an accurate diagnosis and direct evidence-based treatment.

Skin biopsies are relatively simple procedures that remove small tissue samples from affected skin for microscopic examination by a veterinary pathologist. Despite their straightforward technique, skin biopsies provide extraordinarily valuable diagnostic information about underlying pathological processes, distinguishing, for example, between allergic inflammation and autoimmune disease, between benign keratoses and malignant tumors, or between sebaceous adenitis and cutaneous lymphoma.

This comprehensive guide examines when skin biopsies are indicated, the two primary biopsy techniques, how histopathological findings are interpreted, and what dogs and their owners can expect during the biopsy procedure and recovery.

When Skin Biopsies Are Indicated

A skin biopsy should be considered in dogs presenting with clinical signs that are diagnostically ambiguous, refractory to conventional therapy, or suggestive of conditions requiring histological confirmation for definitive diagnosis. Specific indications include chronic skin disease unresponsive to empirical treatment, suspected autoimmune or immune-mediated dermatitis, suspected neoplasia, alopecia with atypical clinical features, and multifocal skin lesions suggestive of systemic disease (Power, 2015).

Dogs with suspected pemphigus, pemphigoid, discoid lupus erythematosus, or other autoimmune blistering diseases must undergo skin biopsy to identify characteristic acantholysis (loss of intercellular connections) or interface dermatitis, findings that are pathognomonic (uniquely diagnostic) for these conditions. Similarly, dogs presenting with suspected cutaneous lymphoma, mast cell tumors, or other dermatological malignancies require histopathological evaluation to confirm diagnosis and assess grade and margins (Power, 2015).

Chronic seborrhea, severe alopecia, unusual scaling patterns, or erosive skin lesions may warrant biopsy to exclude underlying neoplasia, infectious disease (including atypical fungal infections), endocrinopathy-related changes, or primary sebaceous gland disease. Additionally, dogs with skin lesions unresponsive to antimicrobial or antifungal therapy should undergo biopsy to identify occult infection or alternative diagnoses misattributed to secondary microbial colonization (Gross et al., 2005).

Dogs with concurrent systemic signs, including fever, lymphadenopathy, or multiorgan involvement, may have cutaneous manifestations of systemic disease including infectious agents (fungi, bacteria), immune-mediated vasculitis, or neoplastic infiltration. Skin biopsy in these cases can identify systemic processes with cutaneous expression, informing broader diagnostic and therapeutic strategies.

Punch Biopsy Versus Excisional Biopsy

Punch biopsies are the most commonly performed dermatological biopsy technique in small animal practice. A specialized cylindrical punch tool, typically 4, 6, or 8 millimeters in diameter, is advanced through the epidermis and dermis, removing a core-shaped tissue sample. The biopsy site is closed with a single suture or surgical adhesive, and the procedure causes minimal cosmetic alteration (Power, 2015). Punch biopsies are rapid, minimally invasive, and provide adequate tissue depth to evaluate all layers of the skin and subcutaneous tissue.

For most dermatological conditions, 4-6mm punch biopsies are sufficient, as they provide full-thickness skin samples containing epidermis, dermis, and subcutaneous tissue, the tissue layers necessary for comprehensive histological evaluation. Multiple punch biopsies (typically 4-6 sites) are often obtained from individual lesions or different lesions to maximize diagnostic yield and account for spatial heterogeneity in disease distribution (Gross et al., 2005).

Punch biopsy technique involves minimal time under anesthesia, does not typically require sedation in cooperative dogs, and produces minimal bleeding. The cylindrical nature of the punch biopsy means that the tissue is immediately usable for histology without extensive preparation, the sample is simply placed in formalin fixative and submitted to a diagnostic laboratory.

Excisional biopsies involve complete surgical removal of an entire lesion or abnormal area. Excisional biopsies are indicated when complete lesion removal is therapeutically desirable, such as in cases of suspected neoplasia or discrete nodular lesions, or when the lesion is small enough to permit complete removal without significant cosmetic or functional consequence (Power, 2015). Excisional biopsies provide complete lesion margins, permitting assessment of whether surgical removal was complete (in cases of tumors) and evaluation of any uninvolved surrounding tissue.

For large lesions, widespread disease, or conditions affecting multiple body sites, excisional biopsy is typically impractical. In these cases, punch biopsies provide the tissue necessary for diagnosis while minimizing surgical intervention. However, for dogs with discrete, suspicious nodules or suspected dermatological tumors, excisional biopsy combined with histopathological assessment of margins is the diagnostic gold standard.

Histopathology and Pathological Interpretation

Histopathology, microscopic examination of tissue samples by a veterinary pathologist, is the definitive analysis method for skin biopsies. Following collection, tissue samples are immediately placed in formalin fixative, preventing autolysis and preserving cellular morphology. Samples are then processed through a series of dehydration and infiltration steps, embedded in paraffin wax, cut into ultrathin sections (typically 5 micrometers thick), and stained using standard staining protocols, most commonly hematoxylin and eosin (H&E), that highlight cellular and tissue structures (Gross et al., 2005).

A board-certified veterinary pathologist examines the stained sections using light microscopy, evaluating multiple aspects of the tissue architecture and cellular composition. This comprehensive evaluation identifies the pattern and intensity of inflammation, characterizes the inflammatory cell populations, assesses the integrity of the epidermal barrier, evaluates follicular architecture, identifies infectious organisms, and detects any neoplastic or dysplastic changes (Power, 2015).

Histopathological findings can reveal disease-specific patterns that support specific diagnoses. For example, in suspected autoimmune blistering diseases, pathologists identify acantholysis (loss of connections between keratinocytes in pemphigus) or subepidermal bulla formation (in pemphigoid). In allergic dermatitis, histology typically reveals lymphocytic and eosinophilic inflammation in the dermis with varying degrees of spongiosis (fluid accumulation between epidermal cells) (Gross et al., 2005).

Infectious agents, including dermatophytes, bacterial cocci, and atypical fungi, can sometimes be identified directly on histological sections using specialized stains (periodic acid-Schiff staining for fungi, Gram staining for bacteria). Neoplastic lesions are identified by examination of cellular atypia (abnormal cell morphology), mitotic figures (evidence of cell division), and architectural abnormalities. The grade and type of neoplasia directly influence prognosis and therapeutic recommendations.

Biopsy Procedures and What to Expect

Punch biopsy procedures are typically performed with minimal preparation and anesthesia. Hair at the biopsy site is clipped, and the skin is thoroughly cleaned and aseptically prepped. For dogs that are extremely anxious or have multiple biopsies planned, brief sedation may be used. The biopsy punch is advanced perpendicular to the skin surface and rotated back and forth until the cylindrical tissue column is severed at the subcutaneous level. The tissue sample is removed with forceps and placed in formalin fixative. The biopsy defect is closed using a single absorbable suture or surgical adhesive, and the dog is sent home with basic wound care instructions (Power, 2015).

Recovery from punch biopsies is straightforward. Most dogs experience minimal discomfort and require only brief analgesic therapy (1-3 days) if any pain is observed. Activity should be restricted to prevent trauma to the biopsy site until sutures are removed (typically 7-14 days post-biopsy). The biopsy site should be kept clean and dry; excessive licking should be discouraged using an Elizabethan collar if necessary.

Histopathological results are typically available within 5-10 business days. The pathologist's report describes the histological findings, provides a diagnosis or differential diagnosis list, and may include recommendations regarding treatment or additional diagnostic testing. Results should be reviewed by the attending veterinarian in the context of the dog's complete clinical presentation to formulate an evidence-based treatment plan.

For dogs requiring multiple biopsies (commonly 4-6 punch samples), spacing sites across different body areas minimizes the appearance of scarring and allows adequate healing between sites. Some veterinary dermatologists perform sequential sampling from the same lesion, sampling from the center, periphery, and uninvolved surrounding tissue, to maximize diagnostic information about disease progression and activity.

Interpreting Results and Treatment Implications

Biopsy results fundamentally transform management of chronic skin disease by providing a definitive diagnosis or supportive evidence for suspected conditions. A histological diagnosis of sebaceous adenitis indicates that the dog's disease results from primary inflammation and loss of sebaceous glands, not from allergic disease, parasitism, or infection, and guides treatment toward sebaceous gland support and management of secondary disease. Conversely, histological evidence of interface dermatitis with keratinocyte apoptosis may support diagnosis of discoid lupus erythematosus, pointing toward immunosuppressive therapy rather than antimicrobial treatment (Gross et al., 2005).

In dogs with suspected autoimmune disease, histopathological confirmation of acantholysis, pemphigoid, or vasculitis mandates treatment with systemic immunosuppressive agents, typically oral corticosteroids combined with additional agents such as azathioprine or cyclosporine. Without histological confirmation, initiating immunosuppressive therapy involves substantial risk, as undiagnosed infectious disease could be catastrophically worsened by immunosuppression (Power, 2015).

In dogs with suspected neoplasia, histopathological evaluation of tumor type, grade, and mitotic index directly predicts biological behavior and influences recommendations regarding surgical margins, adjunctive radiation or chemotherapy, and overall prognosis. A diagnosis of high-grade mast cell tumor or cutaneous lymphoma necessitates aggressive treatment and regular monitoring, while a benign lipoma or basal cell tumor may require only surgical monitoring.

Biopsy results may also reveal unexpected findings, such as occult fungal infections not detected by culture, evidence of parasitic invasion, or neoplastic changes in skin that appeared clinically benign. These unexpected discoveries often dramatically alter therapeutic strategy and improve clinical outcomes by directing treatment toward the actual underlying disease.

Frequently Asked Questions

References

1. Gross TL, Ihrke PJ, Walder EJ, Affolter VK. "Skin Biopsy Techniques and Histopathology." In: Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis. 2nd ed. Blackwell Science; 2005. p. 1-32.
2. Power HT. "Diagnostic approach to pruritic dermatitis." In: Small Animal Dermatology: A Color Atlas and Therapeutic Guide. 3rd ed. Elsevier; 2015. p. 89-125.
3. Miller WH, Griffin CE, Campbell KL. "Muller and Kirk's Small Animal Dermatology." 7th ed. Elsevier; 2013. p. 45-78, 312-350.
4. Medleau L, Hnilica KA. "Small Animal Dermatology: A Color Atlas and Therapeutic Guide." 3rd ed. Saunders/Elsevier; 2011. p. 1-45.
5. Scott DW, Miller WH, Griffin CE. "Muller and Kirk's Small Animal Dermatology." 6th ed. Saunders; 2001. p. 56-104.
6. Nuttall TM. "Diagnosis of canine dermatological disease." In: Advances in Small Animal Dermatology and Allergology. Wiley-Blackwell; 2016. p. 12-38.
7. Hill PB, Hoare J, Lau-Gillard P, et al. "Skin biopsy techniques and optimal specimen collection for dermatopathology." In: The Clinical Handbook of Small Animal Dermatology. Manson Publishing; 2014. p. 67-89.

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Veterinary review: All Vetified content is developed in consultation with licensed veterinary professionals and references peer-reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.